Peter Devilee

Has grant

Professor in Tumor Genetics, section leader

Leiden University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Medical Science Medical Science professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peter Devilee is a Professor in Tumor Genetics and section leader at Leiden University Medical Centre in the Netherlands. His research focuses on the genetic factors influencing breast cancer and tumors, with recent publications addressing various aspects of tumor genetics, including germline variants and their phenotypic impacts. He has contributed significantly to understanding the molecular mechanisms underlying cancer susceptibility and management, particularly in high-risk populations.

Recent Grants

Grant: Close

Breast Cancer Risk After Diagnostic Gene Sequencing

Open Date: 2015-09-01

Close Date: 2020-08-01

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (21)

Elena Bueno Martínez

Profesora Ayudante Doctora

Universidad de Valladolid

SPAIN

Peter Devilee

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases

LncRNA LITATS1 suppresses TGF‐β‐induced EMT and cancer cell plasticity by potentiating TβRI degradation

SDHBvariant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma

Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry

Hypothesis: Why Different Types of SDH Gene Variants Cause Divergent Tumor Phenotypes

Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study

<i>RAD51D</i> Aberrant Splicing in Breast Cancer: Identification of Splicing Regulatory Elements and Minigene-Based Evaluation of 53 DNA Variants

Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)

Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the <i>RAD51C</i> Gene

Clustering of known low and moderate risk alleles rather than a novel recessive high‐risk gene in non‐BRCA1/2 sib trios affected with breast cancer

Collaborators (21)

Elena Bueno Martínez

Maaike P.G. Vreeswijk

William Newman

Gary Bader

Dominique Stoppa-Lyonnet

Anna Jakubowska

Emmanouil Saloustros

John W. M. Martens

Paolo Radice

Eladio Andrés Velasco-Sampedro

Anna Gonzalez-Neira

Stig E. Bojesen

Bing-Jian Feng

Jean-Sébastien Paquette

Peter Hillemanns

Sabine Behrens

Corinna Ernst

mikael eriksson

Felix Grassmann

Natalia Bogdanova

Philippe Després

Make your next move.